Literature DB >> 23664871

Development of a triclosan scaffold which allows for adaptations on both the A- and B-ring for transport peptides.

Stephen P Muench1, Jozef Stec, Ying Zhou, Gustavo A Afanador, Martin J McPhillie, Mark R Hickman, Patty J Lee, Susan E Leed, Jennifer M Auschwitz, Sean T Prigge, David W Rice, Rima McLeod.   

Abstract

The enoyl acyl-carrier protein reductase (ENR) enzyme is harbored within the apicoplast of apicomplexan parasites providing a significant challenge for drug delivery, which may be overcome through the addition of transductive peptides, which facilitates crossing the apicoplast membranes. The binding site of triclosan, a potent ENR inhibitor, is occluded from the solvent making the attachment of these linkers challenging. Herein, we have produced 3 new triclosan analogs with bulky A- and B-ring motifs, which protrude into the solvent allowing for the future attachment of molecular transporters for delivery.
Copyright © 2013 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23664871      PMCID: PMC3683578          DOI: 10.1016/j.bmcl.2013.04.035

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  35 in total

Review 1.  The apicoplast.

Authors:  Geoffrey Ian McFadden
Journal:  Protoplasma       Date:  2010-12-17       Impact factor: 3.356

2.  X-ray crystallographic analysis of the complexes of enoyl acyl carrier protein reductase of Plasmodium falciparum with triclosan variants to elucidate the importance of different functional groups in enzyme inhibition.

Authors:  Koustav Maity; Saligram Prabhakar Bhargav; Banumathi Sankaran; Namita Surolia; Avadhesha Surolia; Kaza Suguna
Journal:  IUBMB Life       Date:  2010-06       Impact factor: 3.885

Review 3.  Antibacterial targets in fatty acid biosynthesis.

Authors:  H Tonie Wright; Kevin A Reynolds
Journal:  Curr Opin Microbiol       Date:  2007-08-17       Impact factor: 7.934

4.  Cyanation of arenes via iridium-catalyzed borylation.

Authors:  Carl W Liskey; Xuebin Liao; John F Hartwig
Journal:  J Am Chem Soc       Date:  2010-08-25       Impact factor: 15.419

5.  Identification and development of novel inhibitors of Toxoplasma gondii enoyl reductase.

Authors:  Suresh K Tipparaju; Stephen P Muench; Ernest J Mui; Sergey N Ruzheinikov; Jeffrey Z Lu; Samuel L Hutson; Michael J Kirisits; Sean T Prigge; Craig W Roberts; Fiona L Henriquez; Alan P Kozikowski; David W Rice; Rima L McLeod
Journal:  J Med Chem       Date:  2010-09-09       Impact factor: 7.446

6.  Synthesis and SAR of novel benzoxaboroles as a new class of β-lactamase inhibitors.

Authors:  Yi Xia; Kathy Cao; Yasheen Zhou; M R K Alley; Fernando Rock; Manisha Mohan; Maliwan Meewan; Stephen J Baker; Sarah Lux; Charles Z Ding; Guofeng Jia; Maureen Kully; Jacob J Plattner
Journal:  Bioorg Med Chem Lett       Date:  2011-02-12       Impact factor: 2.823

7.  Novel N-benzoyl-2-hydroxybenzamide disrupts unique parasite secretory pathway.

Authors:  Alina Fomovska; Qingqing Huang; Kamal El Bissati; Ernest J Mui; William H Witola; Gang Cheng; Ying Zhou; Caroline Sommerville; Craig W Roberts; Sam Bettis; Sean T Prigge; Gustavo A Afanador; Mark R Hickman; Patty J Lee; Susan E Leed; Jennifer M Auschwitz; Marco Pieroni; Jozef Stec; Stephen P Muench; David W Rice; Alan P Kozikowski; Rima McLeod
Journal:  Antimicrob Agents Chemother       Date:  2012-02-21       Impact factor: 5.191

8.  The fatty acid biosynthesis enzyme FabI plays a key role in the development of liver-stage malarial parasites.

Authors:  Min Yu; T R Santha Kumar; Louis J Nkrumah; Alida Coppi; Silke Retzlaff; Celeste D Li; Brendan J Kelly; Pedro A Moura; Viswanathan Lakshmanan; Joel S Freundlich; Juan-Carlos Valderramos; Catherine Vilcheze; Mark Siedner; Jennifer H-C Tsai; Brie Falkard; Amar Bir Singh Sidhu; Lisa A Purcell; Paul Gratraud; Laurent Kremer; Andrew P Waters; Guy Schiehser; David P Jacobus; Chris J Janse; Arba Ager; William R Jacobs; James C Sacchettini; Volker Heussler; Photini Sinnis; David A Fidock
Journal:  Cell Host Microbe       Date:  2008-12-11       Impact factor: 21.023

9.  Malaria pulls a FASt one.

Authors:  Maroya D Spalding; Sean T Prigge
Journal:  Cell Host Microbe       Date:  2008-12-11       Impact factor: 21.023

10.  Effect of the explicit flexibility of the InhA enzyme from Mycobacterium tuberculosis in molecular docking simulations.

Authors:  Elisangela M L Cohen; Karina S Machado; Marcelo Cohen; Osmar Norberto de Souza
Journal:  BMC Genomics       Date:  2011-12-22       Impact factor: 3.969

View more
  3 in total

1.  Triclosan inhibits the growth of Neospora caninum in vitro and in vivo.

Authors:  Heng Zhang; Jing Liu; Congshan Yang; Yong Fu; Jianhai Xu; Qun Liu
Journal:  Parasitol Res       Date:  2019-09-05       Impact factor: 2.289

Review 2.  Drugs in development for toxoplasmosis: advances, challenges, and current status.

Authors:  P Holland Alday; Joseph Stone Doggett
Journal:  Drug Des Devel Ther       Date:  2017-01-25       Impact factor: 4.162

3.  A Multilayer Network Approach for Guiding Drug Repositioning in Neglected Diseases.

Authors:  Ariel José Berenstein; María Paula Magariños; Ariel Chernomoretz; Fernán Agüero
Journal:  PLoS Negl Trop Dis       Date:  2016-01-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.